Jazz Pharmaceuticals Plc (JAZZ)
235.67
+2.66
(+1.14%)
USD |
NASDAQ |
Oct 02, 16:00
235.53
-0.14
(-0.06%)
After-Hours: 20:00
Jazz Pharmaceuticals Gross Profit Margin (Quarterly) : 76.30% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 76.30% |
| March 31, 2026 | 71.34% |
| December 31, 2025 | 73.01% |
| September 30, 2025 | 73.60% |
| June 30, 2025 | 73.38% |
| March 31, 2025 | 71.15% |
| December 31, 2024 | 73.57% |
| September 30, 2024 | 74.50% |
| June 30, 2024 | 74.10% |
| March 31, 2024 | 72.15% |
| December 31, 2023 | 74.43% |
| September 30, 2023 | 73.56% |
| June 30, 2023 | 73.93% |
| March 31, 2023 | 68.81% |
| December 31, 2022 | 68.65% |
| September 30, 2022 | 70.78% |
| June 30, 2022 | 70.77% |
| March 31, 2022 | 64.68% |
| December 31, 2021 | 67.28% |
| September 30, 2021 | 63.61% |
| June 30, 2021 | 65.46% |
| March 31, 2021 | 82.16% |
| December 31, 2020 | 82.38% |
| September 30, 2020 | 81.90% |
| June 30, 2020 | 83.82% |
| Date | Value |
|---|---|
| March 31, 2020 | 82.89% |
| December 31, 2019 | 64.10% |
| September 30, 2019 | 82.47% |
| June 30, 2019 | 83.29% |
| March 31, 2019 | 82.21% |
| December 31, 2018 | 84.70% |
| September 30, 2018 | 84.33% |
| June 30, 2018 | 82.08% |
| March 31, 2018 | 80.45% |
| December 31, 2017 | 82.09% |
| September 30, 2017 | 80.94% |
| June 30, 2017 | 86.09% |
| March 31, 2017 | 86.51% |
| December 31, 2016 | 84.92% |
| September 30, 2016 | 86.43% |
| June 30, 2016 | 86.69% |
| March 31, 2016 | 86.29% |
| December 31, 2015 | 86.00% |
| September 30, 2015 | 84.01% |
| June 30, 2015 | 86.37% |
| March 31, 2015 | 82.87% |
| December 31, 2014 | 81.48% |
| September 30, 2014 | 81.20% |
| June 30, 2014 | 78.20% |
| March 31, 2014 | 74.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| GH Research Plc | -- |
| Cosmo NV | -- |
| Axsome Therapeutics, Inc. | 92.47% |
| Eli Lilly & Co. | 85.78% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 22.06% |
| Return on Assets | 8.27% |
| Return on Invested Capital | 9.92% |
| Profit Margin (Quarterly) | 15.96% |
| Operating Margin (Quarterly) | 26.91% |
| Return on Net Operating Assets | 11.90% |